NWF Advisory Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

NWF Advisory Services’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$470K	Sell	1,600 -80	-5%	-$22.7K	0.04%	234
2026 Q1	$468K	Hold	1,680	–	–	0.05%	220
2025 Q4	$509K	Hold	1,680	–	–	0.06%	209
2025 Q3	$471K	Sell	1,680 -100	-6%	-$27.2K	0.05%	222
2025 Q2	$430K	Hold	1,780	–	–	0.05%	232
2025 Q1	$434K	Buy	+1,780	New	+$535K	0.06%	192
2024 Q4	–	Sell	-1,780	Closed	-$596K	–	299
2024 Q3	$596K	Hold	1,780	–	–	0.09%	147
2024 Q2	$486K	Hold	1,780	–	–	0.08%	161
2024 Q1	$616K	Hold	1,780	–	–	0.1%	140
2023 Q4	$575K	Hold	1,780	–	–	0.11%	133
2023 Q3	$638K	Hold	1,780	–	–	0.15%	112
2023 Q2	$675K	Hold	1,780	–	–	0.16%	112
2023 Q1	$675K	Buy	+1,780	New	+$833K	0.16%	112

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NWF Advisory Services's BIO Position: Q2 2026 in Review

NWF Advisory Services reduced its Bio-Rad Laboratories Class A (BIO) stake by 4.8% in Q2 2026, selling an estimated $22.7K and leaving 1,600 shares worth $470K. The position accounts for 0.04% of the portfolio, ranked #234.

NWF Advisory Services first reported a position in BIO in Q1 2023 and has held it in 13 quarters since. The position peaked at $675K in Q2 2023. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

NWF Advisory Services held 1,600 shares of Bio-Rad Laboratories Class A worth $470K as of Q2 2026.
NWF Advisory Services sold 80 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $22.7K.
Bio-Rad Laboratories Class A made up 0.04% of NWF Advisory Services's portfolio in Q2 2026, its #234 holding.
NWF Advisory Services first reported a position in Bio-Rad Laboratories Class A in Q1 2023 and has held it in 13 quarters since.
NWF Advisory Services's Bio-Rad Laboratories Class A position peaked at $675K in Q2 2023.
399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on NWF Advisory Services's 13F filing for Q2 2026, filed 29 Jul 2026.